October 2011 Br J Cardiol 2011;18:217
Drs Ewan J McKay, Tina Tian, Nick Gerning, Chris Sawh, Pankaj Garg, John Purvis, Sinead Hughes and Mark Noble
Abstract
When the dentist said: “Be still your beating heart!”
Dear Sirs,
We all often encounter a patient history and apparent presenting complaint that we can not precisely and cleverly explain. Our patient, Mr BW, a fit and active 53-year-old man, attended a routine appointment as an outpatient. He had done this many times previously as he was experiencing difficuties with heart rate control and troubling symptoms secondary to atrial fibrillation (AF). Coincidentally, he had also had amalgam dental fillings drilled some 18 months previously.
Since then, his cardiac problems had escalated. There appeared no clear causality between the fillings a
|
Full text
February 2011 Br J Cardiol 2011;18:11-3
Abstract
Highlights of the American Heart Association 2010 meeting held in November 2010, in Chicago, USA, included a breakthrough for the treatment of resistant hypertension, and another oral anticoagulant that could be used instead of warfarin in atrial fibrillation patients, without the need for monitoring.
RAFT: CRT reduces deaths and hospitalisations in mild heart failure
Adding cardiac-resynchronisation therapy (CRT) to implantable cardioverter defibrillator (ICD) and medication, led to a reduction in deaths and heart failure hospitalistions among patients with mild-to-moderate symptoms of heart failure in the RAFT (Resynchronisation-Defibrilla
|
Full text
May 2010 Br J Cardiol 2010;17:111-5
BJ Cardio Staff
Abstract
ACCORD/INVEST: do not aim for normal blood pressure in diabetes patients with CAD
The results of two trials comparing intensive versus more conventional blood pressure lowering in patients with diabetes at high cardiovascular risk have suggested that intensive treatment is not necessary and may be harmful in this population.
In the ACCORD BP (Action to Control Cardiovascular Risk in Diabetes – Blood Pressure) trial, while intensive blood pressure treatment did reduce the risk of stroke, it failed to reduce the overall risk of cardiovascular events in patients and was associated with an increase in adverse events due to antihypertensive ther
|
Full text
March 2010 Br J Cardiol 2010;17:81-5
Kathryn E Griffith, Philip A Kalra
Abstract
(more…)
|
Full text
September 2006 Br J Cardiol 2006;13:332-37
BJCardio editorial team
Abstract
No content available
|
Full text
July 2006 Br J Cardiol 2006;13:233-7
Bryan Williams
Abstract
No content available
|
Full text
September 2005 Br J Cardiol 2005;12:387-91
Mohamed Bakr, Derek G Waller
Abstract
No content available
|
Full text
March 2005 Br J Cardiol 2005;12:156-60
Terry McCormack, Mark Davis
Abstract
No content available
|
Full text
July 2004 Br J Cardiol 2004;11:292-9
Andrei C Sposito, Jose Augusto S Barreto-Filho
Abstract
No content available
|
Full text
July 2003 Br J Cardiol 2003;10:310-4
Mike Mead
Abstract
No content available
|
Full text